Genmab appoints chief medical officer

On Monday, Genmab announces that the firm has appointed Tahamtan Ahmadi to the newly created position of chief medical officer

Photo: Lars Møller / Genmab / PR

On Monday, biotech firm Genmab has appointed Tahamtan Ahmadi to be the firm's chief medical officer, from which position he will be responsible for the firm's experimental medicines, states the company in a press release.

The position is newly created, and on March 1 Tahamtan Ahmadi, who currently heads the biotech firm's oncology unit, will take on the new role.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs